These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 34206680)

  • 21. Cathodic voltage-controlled electrical stimulation of titanium for prevention of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii biofilm infections.
    Canty M; Luke-Marshall N; Campagnari A; Ehrensberger M
    Acta Biomater; 2017 Jan; 48():451-460. PubMed ID: 27890730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
    Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
    Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Existence of Biofilm and Biofilm-Associated Virulence Genes in Multi-Drug Resistant Invasive Acinetobacter baumannii Isolates].
    Altınok Ö; Boral B; Ergin A; Eser ÖK
    Mikrobiyol Bul; 2020 Jan; 54(1):40-49. PubMed ID: 32050877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces.
    Greene C; Wu J; Rickard AH; Xi C
    Lett Appl Microbiol; 2016 Oct; 63(4):233-9. PubMed ID: 27479925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant
    Ranjbar R; Farahani A
    Antimicrob Resist Infect Control; 2019; 8():172. PubMed ID: 31719975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug Resistant
    Sherif MM; Elkhatib WF; Khalaf WS; Elleboudy NS; Abdelaziz NA
    Front Microbiol; 2021; 12():716627. PubMed ID: 34650528
    [No Abstract]   [Full Text] [Related]  

  • 27. Amide side chain amphiphilic polymers disrupt surface established bacterial bio-films and protect mice from chronic Acinetobacter baumannii infection.
    Uppu DS; Samaddar S; Ghosh C; Paramanandham K; Shome BR; Haldar J
    Biomaterials; 2016 Jan; 74():131-43. PubMed ID: 26454051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of
    Al-Kadmy IMS; Ali ANM; Salman IMA; Khazaal SS
    New Microbes New Infect; 2018 Jan; 21():51-57. PubMed ID: 29204285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between the biofilm-forming ability, biofilm-related genes and antimicrobial resistance of Acinetobacter baumannii].
    Han X; Li Q; Shen L; Hu D; Qu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Sep; 26(9):639-43. PubMed ID: 25230865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors mediating
    Upmanyu K; Haq QMR; Singh R
    Curr Res Microb Sci; 2022; 3():100131. PubMed ID: 35909621
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of the Different Stages of Biofilm Formation and Antibiotic Susceptibility in a Clinical
    Da Cunda P; Iribarnegaray V; Papa-Ezdra R; Bado I; González MJ; Zunino P; Vignoli R; Scavone P
    Microb Drug Resist; 2020 Jun; 26(6):569-575. PubMed ID: 31895639
    [No Abstract]   [Full Text] [Related]  

  • 32. Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development.
    Saipriya K; Swathi CH; Ratnakar KS; Sritharan V
    J Appl Microbiol; 2020 Jan; 128(1):15-27. PubMed ID: 31102552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
    Navon-Venezia S; Ben-Ami R; Carmeli Y
    Curr Opin Infect Dis; 2005 Aug; 18(4):306-13. PubMed ID: 15985826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiofilm and antivirulence efficacy of myrtenol enhances the antibiotic susceptibility of Acinetobacter baumannii.
    Selvaraj A; Valliammai A; Sivasankar C; Suba M; Sakthivel G; Pandian SK
    Sci Rep; 2020 Dec; 10(1):21975. PubMed ID: 33319862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current treatment strategies for targeting virulence factors and biofilm formation in
    Rajangam SL; Narasimhan MK
    Future Microbiol; 2024 Apr; ():. PubMed ID: 38683166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of lectin with antibacterial, antibiofilm and antiproliferative activities from Acinetobacter baumannii of environmental origin.
    Alyousef AA; Alqasim A; Aloahd MS
    J Appl Microbiol; 2018 May; 124(5):1139-1146. PubMed ID: 29349932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GATR-3, a Peptide That Eradicates Preformed Biofilms of Multidrug-Resistant
    van Hoek ML; Alsaab FM; Carpenter AM
    Antibiotics (Basel); 2023 Dec; 13(1):. PubMed ID: 38247598
    [No Abstract]   [Full Text] [Related]  

  • 38.
    Denysko TV; Nazarchuk OA; Gruzevskyi O; Bahniuk NÀ; Dmytriiev DV; Chornopyschuk RM; Bebyk VV
    Front Microbiol; 2022; 13():932467. PubMed ID: 36267170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron limitation enhances acyl homoserine lactone (AHL) production and biofilm formation in clinical isolates of Acinetobacter baumannii.
    Modarresi F; Azizi O; Shakibaie MR; Motamedifar M; Mosadegh E; Mansouri S
    Virulence; 2015; 6(2):152-61. PubMed ID: 25622119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocide susceptibilities and biofilm-forming capacities of Acinetobacter baumannii clinical isolates from Malaysia.
    Nor A'shimi MH; Alattraqchi AG; Mohd Rani F; A Rahman NI; Ismail S; Abdullah FH; Othman N; Cleary DW; Clarke SC; Yeo CC
    J Infect Dev Ctries; 2019 Jul; 13(7):626-633. PubMed ID: 32065820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.